Bringing sniffles and sneezes and perhaps a sore throat and annoying cough, the common cold catches all of us from time to time.
With kids getting as many as eight colds per year or more, this contagious viral infection of the upper respiratory tract is the most common infectious disease in the United States and the No. 1 reason kids visit the doctor and stay home from school
Wednesday, June 25, 2008
Transmission
The common cold virus is transmitted between people by one of two mechanisms:
in aerosol form generated by coughing, sneezing.
from contact with the saliva or nasal secretions of an infected person, either directly or from contaminated surfaces.
Symptoms are not necessary for viral shedding or transmission, as a percentage of asymptomatic subjects exhibit viruses in nasal swabs.[7]
The virus enters the cells of the lining of the nasopharynx (the area between the nose and throat), and rapidly multiplies. The major entry point is normally the nose, but can also be the eyes (in this case drainage into the nasopharynx would occur through the nasolacrimal duct).
in aerosol form generated by coughing, sneezing.
from contact with the saliva or nasal secretions of an infected person, either directly or from contaminated surfaces.
Symptoms are not necessary for viral shedding or transmission, as a percentage of asymptomatic subjects exhibit viruses in nasal swabs.[7]
The virus enters the cells of the lining of the nasopharynx (the area between the nose and throat), and rapidly multiplies. The major entry point is normally the nose, but can also be the eyes (in this case drainage into the nasopharynx would occur through the nasolacrimal duct).
Symptoms
After initial infection, the viral replication cycle begins within 8 to 12 hours.[8] Symptoms can occur shortly thereafter, and usually begin within 2 to 5 days after infection, although occasionally in as little as 10 hours after infection.[8] The first indication of a cold is often a sore or scratchy throat. Other common symptoms are runny nose, congestion, sneezing and cough. These are sometimes accompanied by muscle aches, fatigue, malaise, headache, weakness, or loss of appetite.[9] Colds occasionally cause fever and can sometimes lead to extreme exhaustion. (However, these symptoms are more usual in influenza, and can differentiate the two infections.) The symptoms of a cold usually resolve after about one week, but can last up to 14 days, with a cough lasting longer than other symptoms. Symptoms may be more severe in infants and young children, and may include fever and hives.[
Prevention
The best way to avoid a cold is to avoid close contact with existing sufferers; to wash hands thoroughly and regularly; and to avoid touching the mouth and face. Anti-bacterial soaps have no effect on the cold virus; it is the mechanical action of hand washing with the soap that removes the virus particles.[14]
In 2002, the Centers for Disease Control and Prevention recommended alcohol-based hand gels as an effective method for reducing infectious viruses on the hands of health care workers.[15] As with hand washing with soap and water, alcohol gels provide no residual protection from re-infection.
The common cold is caused by a large variety of viruses, which mutate quite frequently during reproduction, resulting in constantly changing virus strains. Thus, successful immunization is highly improbable.
In 2002, the Centers for Disease Control and Prevention recommended alcohol-based hand gels as an effective method for reducing infectious viruses on the hands of health care workers.[15] As with hand washing with soap and water, alcohol gels provide no residual protection from re-infection.
The common cold is caused by a large variety of viruses, which mutate quite frequently during reproduction, resulting in constantly changing virus strains. Thus, successful immunization is highly improbable.
Treatment
As there is no medically proven and accepted medication directly targeting the causative agent, there is no cure for the common cold. Treatment is limited to symptomatic supportive options, maximizing the comfort of the patient, and limiting complications and harmful sequelae.
The common cold is self-limiting, and the host's immune system effectively deals with the infection. Within a few days, the body's humoral immune response begins producing specific antibodies that can prevent the virus from infecting cells. Additionally, as part of the cell-mediated immune response, leukocytes destroy the virus through phagocytosis and destroy infected cells to prevent further viral replication. In healthy, immunocompetent individuals, the common cold resolves in seven days on average.
There are a number of effective treatments which, rather than treat the viral infection, focus on relieving the symptoms. For some people, colds are relatively minor inconveniences and they can go on with their daily activities with tolerable discomfort. This discomfort has to be weighed against the price and possible side effects of the remedies.
analgesics such as aspirin or paracetamol (acetaminophen), as well as localised versions targeting the throat (often delivered in lozenge form)
nasal decongestants such as pseudoephedrine or oxymetazoline which reduce the inflammation in the nasal passages by constricting dilated local blood vessels
cough suppressants such as dextromethorphan which suppress the cough reflex.
first-generation anti-histamines such as brompheniramine, chlorpheniramine, diphenhydramine and clemastine (which reduce mucus gland secretion and thus combat blocked/runny noses but also may make the user drowsy). Second-generation anti-histamines do not have a useful effect on colds.
The common cold is self-limiting, and the host's immune system effectively deals with the infection. Within a few days, the body's humoral immune response begins producing specific antibodies that can prevent the virus from infecting cells. Additionally, as part of the cell-mediated immune response, leukocytes destroy the virus through phagocytosis and destroy infected cells to prevent further viral replication. In healthy, immunocompetent individuals, the common cold resolves in seven days on average.
There are a number of effective treatments which, rather than treat the viral infection, focus on relieving the symptoms. For some people, colds are relatively minor inconveniences and they can go on with their daily activities with tolerable discomfort. This discomfort has to be weighed against the price and possible side effects of the remedies.
analgesics such as aspirin or paracetamol (acetaminophen), as well as localised versions targeting the throat (often delivered in lozenge form)
nasal decongestants such as pseudoephedrine or oxymetazoline which reduce the inflammation in the nasal passages by constricting dilated local blood vessels
cough suppressants such as dextromethorphan which suppress the cough reflex.
first-generation anti-histamines such as brompheniramine, chlorpheniramine, diphenhydramine and clemastine (which reduce mucus gland secretion and thus combat blocked/runny noses but also may make the user drowsy). Second-generation anti-histamines do not have a useful effect on colds.
Tuesday, June 24, 2008
What is Hepatitis?
Hepatitis A
HAV is a liver disease caused by the hepatitis A virus. In the United States, HAV can occur in situations ranging from isolated cases of disease to widespread epidemics. Good handwashing and proper sanitation can help prevent spread. Vaccines are also available for long-term prevention of HAV infection in persons 2 years of age and older. Immune globulin is available for short-term prevention of hepatitis A.
Hepatitis B
HBV is a serious disease caused by a virus that attacks the liver. HBV can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. HBV can affect anyone. Each year in the United States, more than 200,000 people of all ages get hepatitis B and close to 5,000 die of sickness caused by HBV. If you have had other forms of hepatitis, you can still get hepatitis B. Vaccines are available for long-term protection of HBV infection. Hepatitis B immune globulin is available for post exposure protection.
Hepatitis C
HCV is a liver disease caused by the hepatitis C virus, which is found in the blood of persons who have this disease. HCV is serious for some persons, but not for others. Some do not feel sick from the disease. Most persons who get HCV carry the virus for the rest of their lives and have some liver damage. Others may develop cirrhosis (scarring) of the liver and liver failure, but this process can take many years.
How can I get it?
HAV is a liver disease caused by the hepatitis A virus. In the United States, HAV can occur in situations ranging from isolated cases of disease to widespread epidemics. Good handwashing and proper sanitation can help prevent spread. Vaccines are also available for long-term prevention of HAV infection in persons 2 years of age and older. Immune globulin is available for short-term prevention of hepatitis A.
Hepatitis B
HBV is a serious disease caused by a virus that attacks the liver. HBV can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. HBV can affect anyone. Each year in the United States, more than 200,000 people of all ages get hepatitis B and close to 5,000 die of sickness caused by HBV. If you have had other forms of hepatitis, you can still get hepatitis B. Vaccines are available for long-term protection of HBV infection. Hepatitis B immune globulin is available for post exposure protection.
Hepatitis C
HCV is a liver disease caused by the hepatitis C virus, which is found in the blood of persons who have this disease. HCV is serious for some persons, but not for others. Some do not feel sick from the disease. Most persons who get HCV carry the virus for the rest of their lives and have some liver damage. Others may develop cirrhosis (scarring) of the liver and liver failure, but this process can take many years.
How can I get it?
How can I get it?
Hepatitis A
Eating raw shellfish harvested from sewage-contaminated water
Swallowing contaminated water or ice
Eating fruits, vegetables, or other food that may have become contaminated during handling
Use of street drugs
HAV is found in the stool of persons with hepatitis A. HAV can affect anyone, and is usually spread from person to person by putting something in the mouth that has been contaminated with the stool of a person infected with hepatitis A. HAV can spread in areas where there are poor sanitary conditions or where good handwashing is not observed. Persons with HAV can spread it to household members or sexual partners.
A person can spread HAV about one week before symptoms appear and during the first week of symptoms. Persons with no symptoms can still spread the virus. This often happens with young children who unknowingly spread HAV to older children and adults.
Casual contact as in the usual office, factory or school setting, does not spread the virus.
Hepatitis B
Direct contact with the blood or body fluids of an infected person
Having sex or sharing neeedles with an infected person
Use of street drugs
Exposure to your infected mother at birth
Women who are infected with HBV can give it to their babies. Babies who get HBV at birth may have the virus for the rest of their lives. They can spread the disease and get cirrhosis of the liver or liver cancer.
Sometimes, people who are infected with HBV never recover fully from the infection. They can remain infectious for the rest of their lives. In the United States, about one million people carry HBV.
HBV is not spread through food or water or by casual contact.
Hepatitis C
Use of tatoo or body piercing tools contaminated with someone else's blood
The artist or piercer not following good health practices, including handwashing and using disposable gloves
Sexual contact with multiple partners
Use of street drugs
The infection is spread by contact with the blood of an infected person. Almost 4 million Americans are infected with the Hepatitis C virus.
Hepatitis C virus is not spread by:
Breast feeding
Sneezing
Hugging
Coughing
Food or water
Sharing eating utensils or drinking glasses
Casual contact
Eating raw shellfish harvested from sewage-contaminated water
Swallowing contaminated water or ice
Eating fruits, vegetables, or other food that may have become contaminated during handling
Use of street drugs
HAV is found in the stool of persons with hepatitis A. HAV can affect anyone, and is usually spread from person to person by putting something in the mouth that has been contaminated with the stool of a person infected with hepatitis A. HAV can spread in areas where there are poor sanitary conditions or where good handwashing is not observed. Persons with HAV can spread it to household members or sexual partners.
A person can spread HAV about one week before symptoms appear and during the first week of symptoms. Persons with no symptoms can still spread the virus. This often happens with young children who unknowingly spread HAV to older children and adults.
Casual contact as in the usual office, factory or school setting, does not spread the virus.
Hepatitis B
Direct contact with the blood or body fluids of an infected person
Having sex or sharing neeedles with an infected person
Use of street drugs
Exposure to your infected mother at birth
Women who are infected with HBV can give it to their babies. Babies who get HBV at birth may have the virus for the rest of their lives. They can spread the disease and get cirrhosis of the liver or liver cancer.
Sometimes, people who are infected with HBV never recover fully from the infection. They can remain infectious for the rest of their lives. In the United States, about one million people carry HBV.
HBV is not spread through food or water or by casual contact.
Hepatitis C
Use of tatoo or body piercing tools contaminated with someone else's blood
The artist or piercer not following good health practices, including handwashing and using disposable gloves
Sexual contact with multiple partners
Use of street drugs
The infection is spread by contact with the blood of an infected person. Almost 4 million Americans are infected with the Hepatitis C virus.
Hepatitis C virus is not spread by:
Breast feeding
Sneezing
Hugging
Coughing
Food or water
Sharing eating utensils or drinking glasses
Casual contact
Who is at risk?
Hepatitis A
You are at risk if you:
Have household or sexual contacts with someone who has HAV
Travel to countries where HAV is common and where clean water and proper sewage disposal are not available
Are a man who has sex with men
Use street drugs
Work in child care centers (especially settings that have children in diapers)
Live or work in an institution for developmentally disabled persons
Work in research laboratory setting (excluding laboratories doing routine testing) and handle HAV-infected non-human primates
Receive factor concentrates for clotting factor disorder
Hepatitis B
You are at risk if you:
Have sexual contact with an infected person
Have multiple sex partners
Are a man who has sex with men
Have household contact with someone who has chronic HBV infection
Work with human blood products
Shoot street drugs
Live or work in a home for the developmentally disabled
Have hemophilia
Travel to areas where HBV is common
Your parents were born in Southeast Asia, Africa, the Amazon Basin in South America, the Pacific Islands and the Middle East
One out of 20 people in the United States will get HBV at some time if not vaccinated.
Hepatitis C
You are at risk if you:
Ever injected street drugs, even if you experimented a few times many years ago
Were treated for clotting problems with a blood product made before 1987
Received a blood transfusion or solid organ transplant (e.g. kidney, liver, heart) before July 1992, or you were notified that you received blood that possibly contained HCV
Were ever on long-term kidney dialysis
Many people who are at risk for HCV are at risk for hepatitis A and hepatitis B. Check with your doctor to see if you should get hapatitis A and B vaccines.
Could I already have hepatitis C?
Ask your doctor for a blood test for hepatitis C.
You are at risk if you:
Have household or sexual contacts with someone who has HAV
Travel to countries where HAV is common and where clean water and proper sewage disposal are not available
Are a man who has sex with men
Use street drugs
Work in child care centers (especially settings that have children in diapers)
Live or work in an institution for developmentally disabled persons
Work in research laboratory setting (excluding laboratories doing routine testing) and handle HAV-infected non-human primates
Receive factor concentrates for clotting factor disorder
Hepatitis B
You are at risk if you:
Have sexual contact with an infected person
Have multiple sex partners
Are a man who has sex with men
Have household contact with someone who has chronic HBV infection
Work with human blood products
Shoot street drugs
Live or work in a home for the developmentally disabled
Have hemophilia
Travel to areas where HBV is common
Your parents were born in Southeast Asia, Africa, the Amazon Basin in South America, the Pacific Islands and the Middle East
One out of 20 people in the United States will get HBV at some time if not vaccinated.
Hepatitis C
You are at risk if you:
Ever injected street drugs, even if you experimented a few times many years ago
Were treated for clotting problems with a blood product made before 1987
Received a blood transfusion or solid organ transplant (e.g. kidney, liver, heart) before July 1992, or you were notified that you received blood that possibly contained HCV
Were ever on long-term kidney dialysis
Many people who are at risk for HCV are at risk for hepatitis A and hepatitis B. Check with your doctor to see if you should get hapatitis A and B vaccines.
Could I already have hepatitis C?
Ask your doctor for a blood test for hepatitis C.
Symptoms
Hepatitis A
Three of every four adults who get HAV have symptoms that usually develop over a period of several days. Children who are infected often have no symptoms.
If you have symptoms:
Your eyes may turn yellow and you may have dark urine
You may be tired
You may lose your appetite
You may have nausea, vomiting, fever, or stomach ache
Unlike HBV and HCV, HAV causes no long-term liver damage, and usually does not cause death. There is no chronic carrier state with HAV. Having had the disease produces lifelong immunity from future HAV infection.
Hepatitis B
You may have hepatitis B (and be spreading the disease) and not know it; sometimes a person with HBV infection has no symptoms at all.
If you have symptoms:
Your eyes or skin may turn yellow
You may lose your appetite
You may have nausea, vomiting, fever, stomach or joint pain
You may feel extremely tired, and not be able to work for weeks or months
Hepatitis C
Most people have no symptoms until the disease is very advanced. Fatigue is most common. Only 25%-30% develop malaise, weakness, or anorexia and some develop jaundice. Fulminant hepatitis with liver failure following acute HCV infection has been reported but is rare.
Why should I be tested for hepatitis C?
Early diagnosis is important so you can:
Be checked for liver disease
Get treatment, if indicated. Drugs are licensed for the treatment of persons with long-term hepatitis C.
Learn how you can protect your liver from further harm
Learn how you can prevent spreading HCV to others
Three of every four adults who get HAV have symptoms that usually develop over a period of several days. Children who are infected often have no symptoms.
If you have symptoms:
Your eyes may turn yellow and you may have dark urine
You may be tired
You may lose your appetite
You may have nausea, vomiting, fever, or stomach ache
Unlike HBV and HCV, HAV causes no long-term liver damage, and usually does not cause death. There is no chronic carrier state with HAV. Having had the disease produces lifelong immunity from future HAV infection.
Hepatitis B
You may have hepatitis B (and be spreading the disease) and not know it; sometimes a person with HBV infection has no symptoms at all.
If you have symptoms:
Your eyes or skin may turn yellow
You may lose your appetite
You may have nausea, vomiting, fever, stomach or joint pain
You may feel extremely tired, and not be able to work for weeks or months
Hepatitis C
Most people have no symptoms until the disease is very advanced. Fatigue is most common. Only 25%-30% develop malaise, weakness, or anorexia and some develop jaundice. Fulminant hepatitis with liver failure following acute HCV infection has been reported but is rare.
Why should I be tested for hepatitis C?
Early diagnosis is important so you can:
Be checked for liver disease
Get treatment, if indicated. Drugs are licensed for the treatment of persons with long-term hepatitis C.
Learn how you can protect your liver from further harm
Learn how you can prevent spreading HCV to others
Prevention
Hepatitis A
Always wash your hands after using the bathroom, changing a diaper, and before eating or preparing food.
Hepatitis A vaccines provide long-term protection against hepatitis A and are licensed for use in persons 2 years of age and older. Children and adults need two shots of hepatitis A vaccine for long-term protection.
Who should receive hepatitis A vaccine?
Persons who work in or travel to areas where hapatitis A is common (first dose should be given at least 4 weeks before travel)
Children in communities with high rates of hepatitis A, such as Alaska Native villages, American Indian reservations, and Pacific Islanders and selected religious communities
Men who have sex with men
Persons who use street drugs
Persons with chronic liver disease
Persons with clotting factor disorders, such as hemophelia
Persons with HAV-infected non-human primates or work with HAV in a research setting (hepatitis A vaccine is not generally recommended for health care workers)
Anyone who wants protection
Hepatitis A is preventable. Get vaccinated!
Hepatitis B
Hepatitis B vaccine is the best protection against HBV. Three doses are needed for complete protection.
Who should get vaccinated?
All babies, beginning at birth, should get hapatitis B vaccine
All children and adolescents who have not been vaccinated
Persons of any age whose behavior puts them at a high risk for HBV infection
Persons whose jobs expose them to human blood
All pregnant women should be tested for HBV early in their pregnancy. Children born to HBV positive mothers should receive vaccine along with hepatitis B immune globulin (called H-BIG) at birth. The vaccine series should be completed during the first 6 months of life.
There is no cure for HBV; this is why prevention is so important. Hepatitis B is preventable. Get vaccinated!
Hepatitis C
An ounce of prevention is worth a pound of cure!
Don't ever shoot drugs. If you shoot drugs, stop and get into a treatment program. If you can't stop, never reuse or share syringes, water, or drug works, and get vaccinated against hepatitis A and hepatitis B.
Do not share toothbrushes, razors, or other personal care articles.
Health care workers should always follow routine barrier precautions and safely handle needles and other sharps.
Get vaccinated for HBV.
Consider the health risks if you are thinking about getting a tatoo or body piercing.
Use latex condoms correctly and every time.
The surest way to prevent the spread of any disease by sex is not to have sex at all.
There is no vaccine to prevent hepatitis C.
Adapted from:
Minnesota Department of Health, Acute Disease Prevention and Control materials;
Hepatitis A and Hepatitis B brochure, August 1999.
Centers for Disease Control and Prevention materials, Hepatitis C brochure, October 1998.
More Information:
Call the Hepatitis Hotline at 1-888-443-7232
Visit the Center for Disease Control and Prevention web site.
Visit the Minnesota Department of Health web site
Always wash your hands after using the bathroom, changing a diaper, and before eating or preparing food.
Hepatitis A vaccines provide long-term protection against hepatitis A and are licensed for use in persons 2 years of age and older. Children and adults need two shots of hepatitis A vaccine for long-term protection.
Who should receive hepatitis A vaccine?
Persons who work in or travel to areas where hapatitis A is common (first dose should be given at least 4 weeks before travel)
Children in communities with high rates of hepatitis A, such as Alaska Native villages, American Indian reservations, and Pacific Islanders and selected religious communities
Men who have sex with men
Persons who use street drugs
Persons with chronic liver disease
Persons with clotting factor disorders, such as hemophelia
Persons with HAV-infected non-human primates or work with HAV in a research setting (hepatitis A vaccine is not generally recommended for health care workers)
Anyone who wants protection
Hepatitis A is preventable. Get vaccinated!
Hepatitis B
Hepatitis B vaccine is the best protection against HBV. Three doses are needed for complete protection.
Who should get vaccinated?
All babies, beginning at birth, should get hapatitis B vaccine
All children and adolescents who have not been vaccinated
Persons of any age whose behavior puts them at a high risk for HBV infection
Persons whose jobs expose them to human blood
All pregnant women should be tested for HBV early in their pregnancy. Children born to HBV positive mothers should receive vaccine along with hepatitis B immune globulin (called H-BIG) at birth. The vaccine series should be completed during the first 6 months of life.
There is no cure for HBV; this is why prevention is so important. Hepatitis B is preventable. Get vaccinated!
Hepatitis C
An ounce of prevention is worth a pound of cure!
Don't ever shoot drugs. If you shoot drugs, stop and get into a treatment program. If you can't stop, never reuse or share syringes, water, or drug works, and get vaccinated against hepatitis A and hepatitis B.
Do not share toothbrushes, razors, or other personal care articles.
Health care workers should always follow routine barrier precautions and safely handle needles and other sharps.
Get vaccinated for HBV.
Consider the health risks if you are thinking about getting a tatoo or body piercing.
Use latex condoms correctly and every time.
The surest way to prevent the spread of any disease by sex is not to have sex at all.
There is no vaccine to prevent hepatitis C.
Adapted from:
Minnesota Department of Health, Acute Disease Prevention and Control materials;
Hepatitis A and Hepatitis B brochure, August 1999.
Centers for Disease Control and Prevention materials, Hepatitis C brochure, October 1998.
More Information:
Call the Hepatitis Hotline at 1-888-443-7232
Visit the Center for Disease Control and Prevention web site.
Visit the Minnesota Department of Health web site
Monday, June 23, 2008
Researchers make HIV grow in monkeys
Animal models are invaluable for studying serious diseases. For example, HIV has been shown to infect chimpanzees, and this has been used to study AIDS in humans. However, not only are chimpanzees endangered species, but the disease follows a different path and does not exhibit the same symptoms. This makes it difficult to study the effect of a potential vaccine. Other approaches have included the use of macaque monkeys, which involves infecting them with Simian Immunodeficiency Virus (SIV), a virus similar to HIV. The downside of this approach is that SIV and HIV are different viruses, so results in the SIV model must be verified for HIV as well [1].
Now, researchers have modified HIV-1, the main form responsible for the AIDS pandemic, so that it will infect macaque monkeys [2]. Two recently discovered cellular mechanisms block HIV from infecting rhesus macaques [3,4]. By swapping sections of genetic material in HIV with their corresponding sections in SIV, Paul Bieniasz and his team hoped to subvert these blocking mechanisms. One section from SIV was first spliced into HIV, and allowed to adapt by exposure to human cells over several weeks, during which time it became able to replicate. The adapted section of the genome was then reinserted into normal HIV-1 clones. The process was then repeated giving four types of virus: the normal virus, viruses with one of the SIV sequences incorporated, and one with both SIV sequences present.
Only the modified virus with both SIV sequences present was able to grow in macaque cells. After another period of adaptation, it grew robustly, giving visible pathological effects. Part of this virus’ genome was then reincorporated into the normal HIV-1 clones to give the final virus, called stHIV-1. This virus replicates quickly in both human and macaque cells. There was surprisingly little change in the genetic material compared to the parent HIV-1 genome. [2]
While it is not yet known whether this virus will provide a suitable model for the disease, having only been tested on cell cultures, it is a significant advance. The creation of chimeric (containing genetic material from different species) viruses has attracted significant interest recently due to the shortcomings of current models. However, despite seeming a simple and obvious approach, the practical realities mean creating effective viruses is difficult. The discovery paves the way for enhanced models that will allow the creation of new therapies and vaccines for a disease that continues to affect a huge number of lives worldwide.
Now, researchers have modified HIV-1, the main form responsible for the AIDS pandemic, so that it will infect macaque monkeys [2]. Two recently discovered cellular mechanisms block HIV from infecting rhesus macaques [3,4]. By swapping sections of genetic material in HIV with their corresponding sections in SIV, Paul Bieniasz and his team hoped to subvert these blocking mechanisms. One section from SIV was first spliced into HIV, and allowed to adapt by exposure to human cells over several weeks, during which time it became able to replicate. The adapted section of the genome was then reinserted into normal HIV-1 clones. The process was then repeated giving four types of virus: the normal virus, viruses with one of the SIV sequences incorporated, and one with both SIV sequences present.
Only the modified virus with both SIV sequences present was able to grow in macaque cells. After another period of adaptation, it grew robustly, giving visible pathological effects. Part of this virus’ genome was then reincorporated into the normal HIV-1 clones to give the final virus, called stHIV-1. This virus replicates quickly in both human and macaque cells. There was surprisingly little change in the genetic material compared to the parent HIV-1 genome. [2]
While it is not yet known whether this virus will provide a suitable model for the disease, having only been tested on cell cultures, it is a significant advance. The creation of chimeric (containing genetic material from different species) viruses has attracted significant interest recently due to the shortcomings of current models. However, despite seeming a simple and obvious approach, the practical realities mean creating effective viruses is difficult. The discovery paves the way for enhanced models that will allow the creation of new therapies and vaccines for a disease that continues to affect a huge number of lives worldwide.
Subscribe to:
Posts (Atom)